Positron Corp (POSC) Stock Price & Analysis
Positron Corp (POSC) rose 0.00% to USD 1.81 as of September 8, 2026 at 16:50 UTC, according to Nexqual real-time market data.
POSC last closed at USD 1.81; the session ranged USD 1.81–1.81 on volume of 100 shares. Market capitalization is —, with a 52-week range of USD 1.27–2.74 (OID). Source: Nexqual, September 8, 2026 at 16:50 UTC.
Key Statistics (as of September 8, 2026 at 16:50 UTC)
| Price | USD 1.81 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.81 |
| Open | USD 1.81 |
| Day Range | USD 1.81 – 1.81 |
| 52-Week Range | USD 1.27 – 2.74 |
| Volume | 100 shares |
| Market Cap | — |
| Exchange | OID |
Technical Analysis (POSC)
Nexqual's technical model rates POSC "STRONG BUY" based on 5 bullish and 0 bearish signals across 126 daily candles, as of September 8, 2026 at 16:50 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.25 (neutral) |
| vs SMA50 | Above (USD 1.7) |
| MACD | 0.01 (positive) |
From Positron Corp's Latest SEC 10-K Filing (filed 2026-03-31)
Partnerships
- Food and Drug Administration ("FDA") Quality System Regulation, as well as other federal, state, and international standards, including those applicable within the European Union.   Research and Development   The Company conducts its research and development activities in collaboration with its strategic partner, Neusoft Medical Systems, which provides expertise in the design, engineering, and manufacturing of advanced medical imaging systems.
- Food and Drug Administration ("FDA") 510(k) clearance.   The Company's collaboration with Neusoft also supports the continued development and production of its PET imaging systems and related technologies.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NIMU | Non-Invasive Monitoring Systems | USD 11 | ▲ 0% |
| ESMC | Escalon Medical Corp. | USD 0.17 | ▼ 2.94% |
| PKTX | ProtoKinetix, Inc. | USD 0 | ▲ 0% |
| PSCO | Protosource Corp. | USD 0.01 | ▲ 0% |
| NEPH | Nephros, Inc. | USD 4.3 | ▲ 2.87% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:50 UTC. This page is informational and not investment advice.